Avallano strengthens leadership with new Chief Strategy Officer

June 26, 2024

To Drive AI-Powered Clinical Research Innovation

GREENVILLE, SC – Avallano, an AI-enabled clinical research company, announced the appointment of Michael A. Ibara, Pharm.D., as Chief Strategy Officer (CSO). Dr. Ibara will lead the company’s global strategic initiatives to transform the clinical trial sector with leading-edge technology solutions.

Dr. Ibara will lead the launch of Avallano’s generative AI technologies, aimed at enhancing clinical research by addressing the challenges faced by patients, sites, and sponsors in executing clinical trials. Avallano’s solutions include personalized patient chat services, AI-driven medical information processing, founded on a market-leading approach to global privacy and patient empowerment. He’ll guide the company in balancing regulatory compliance requirements with the capabilities of explainable AI.

“Michael’s extensive experience in the biopharmaceutical industry and his innovative approach to data and clinical operations make him the perfect fit for Avallano,” said Paul Della Maggiora, Co-Founder and CEO.

Prior to joining Avallano, Dr. Ibara served as Chief Data Officer at Elligo Health Solutions, where he created an innovative approach to utilize electronic health record (EHR) data for clinical trial feasibilities and operations. In addition to developing the first-ever effort to automate the collection of adverse events directly from EHRs, he has held senior leadership positions in large biopharmaceutical and CRO organizations. Dr. Ibara holds a Pharm.D. from the University of Michigan and a Fellowship from the University of North Carolina and Burroughs Wellcome Co.



About Avallano

Imagine a world where your life sciences data aren’t just numbers and figures but a powerful tool to drive engagement and education. We transform your data into actionable insights and harness its potential to create impactful patient and community engagement apps. We’re not just about data; we’re about making research benefits tangible and understandable to patients and communities. Turn your data into action and unlock the true potential of your research network.


Michael Ibara

[email protected]